Global Biopharmaceutical CDMO Competitive Landscape Professional Research Report 2024

Research Summary

A biopharmaceutical Contract Development and Manufacturing Organization (CDMO) is a company that provides contract services for the development, manufacturing, and testing of biopharmaceutical products on behalf of pharmaceutical and biotechnology companies. These CDMOs offer a comprehensive range of services, including process development, analytical testing, formulation development, cell line development, and manufacturing of biologics such as monoclonal antibodies, recombinant proteins, vaccines, gene therapies, and cell therapies. By outsourcing these activities to a CDMO, companies can leverage the CDMO's expertise, facilities, and resources to accelerate product development, reduce costs, and focus on core competencies while ensuring quality, safety, and compliance with regulatory standards.

According to DIResearch's in-depth investigation and research, the global Biopharmaceutical CDMO market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Biopharmaceutical CDMO include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, WuXi AppTech, Recipharm, Thermo Fisher Scientific, AGC Biologics, Rentschler Biopharma, KBI Biopharma, Siegfried, Aenova Group, GenScript, ProBioGen, Northway Biotech, 3P Biopharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Biopharmaceutical CDMO. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Biopharmaceutical CDMO market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Biopharmaceutical CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biopharmaceutical CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Biopharmaceutical CDMO Include:

Lonza

Catalent

Samsung Biologics

FUJIFILM Diosynth Biotechnologies

Boehringer Ingelheim

WuXi AppTech

Recipharm

Thermo Fisher Scientific

AGC Biologics

Rentschler Biopharma

KBI Biopharma

Siegfried

Aenova Group

GenScript

ProBioGen

Northway Biotech

3P Biopharmaceuticals

Biopharmaceutical CDMO Product Segment Include:

Cell and Gene Therapies

Antibodies

Vaccines

Other

Biopharmaceutical CDMO Product Application Include:

SMBs

Large Companies

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Biopharmaceutical CDMO Industry PESTEL Analysis

Chapter 3: Global Biopharmaceutical CDMO Industry Porter's Five Forces Analysis

Chapter 4: Global Biopharmaceutical CDMO Major Regional Market Size and Forecast Analysis

Chapter 5: Global Biopharmaceutical CDMO Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Biopharmaceutical CDMO Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Biopharmaceutical CDMO Market Overview

1.1 Product Definition and Statistical Scope

1.2 Biopharmaceutical CDMO Product by Type

1.2.1 Global Biopharmaceutical CDMO Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Cell and Gene Therapies

1.2.3 Antibodies

1.2.4 Vaccines

1.2.5 Other

1.3 Biopharmaceutical CDMO Product by Application

1.3.1 Global Biopharmaceutical CDMO Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 SMBs

1.3.3 Large Companies

1.4 Global Biopharmaceutical CDMO Market Revenue Analysis (2019-2030)

1.5 Biopharmaceutical CDMO Market Development Status and Trends

1.5.1 Biopharmaceutical CDMO Industry Development Status Analysis

1.5.2 Biopharmaceutical CDMO Industry Development Trends Analysis

2 Biopharmaceutical CDMO Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Biopharmaceutical CDMO Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Biopharmaceutical CDMO Market Analysis by Regions

4.1 Biopharmaceutical CDMO Overall Market: 2023 VS 2024 VS 2030

4.2 Global Biopharmaceutical CDMO Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Biopharmaceutical CDMO Revenue and Market Share by Region (2019-2024)

4.2.2 Global Biopharmaceutical CDMO Revenue Forecast by Region (2025-2030)

5 Global Biopharmaceutical CDMO Market Size by Type and Application

5.1 Global Biopharmaceutical CDMO Market Size by Type

5.2 Global Biopharmaceutical CDMO Market Size by Application

6 North America

6.1 North America Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Biopharmaceutical CDMO Market Size by Type

6.4 North America Biopharmaceutical CDMO Market Size by Application

6.5 North America Biopharmaceutical CDMO Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Biopharmaceutical CDMO Market Size by Type

7.4 Europe Biopharmaceutical CDMO Market Size by Application

7.5 Europe Biopharmaceutical CDMO Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Biopharmaceutical CDMO Market Size by Type

8.4 China Biopharmaceutical CDMO Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Biopharmaceutical CDMO Market Size by Type

9.4 APAC (excl. China) Biopharmaceutical CDMO Market Size by Application

9.5 APAC (excl. China) Biopharmaceutical CDMO Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Biopharmaceutical CDMO Market Size by Type

10.4 Latin America Biopharmaceutical CDMO Market Size by Application

10.5 Latin America Biopharmaceutical CDMO Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Biopharmaceutical CDMO Market Size by Type

11.4 Middle East & Africa Biopharmaceutical CDMO Market Size by Application

11.5 Middle East & Africa Biopharmaceutical CDMO Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Biopharmaceutical CDMO Market Revenue by Key Manufacturers (2020-2024)

12.2 Biopharmaceutical CDMO Competitive Landscape Analysis and Market Dynamic

12.2.1 Biopharmaceutical CDMO Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Lonza

13.1.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Lonza Biopharmaceutical CDMO Product Portfolio

13.1.3 Lonza Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Catalent

13.2.1 Catalent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Catalent Biopharmaceutical CDMO Product Portfolio

13.2.3 Catalent Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Samsung Biologics

13.3.1 Samsung Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Samsung Biologics Biopharmaceutical CDMO Product Portfolio

13.3.3 Samsung Biologics Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 FUJIFILM Diosynth Biotechnologies

13.4.1 FUJIFILM Diosynth Biotechnologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Product Portfolio

13.4.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Boehringer Ingelheim

13.5.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Boehringer Ingelheim Biopharmaceutical CDMO Product Portfolio

13.5.3 Boehringer Ingelheim Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 WuXi AppTech

13.6.1 WuXi AppTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 WuXi AppTech Biopharmaceutical CDMO Product Portfolio

13.6.3 WuXi AppTech Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Recipharm

13.7.1 Recipharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Recipharm Biopharmaceutical CDMO Product Portfolio

13.7.3 Recipharm Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Thermo Fisher Scientific

13.8.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Thermo Fisher Scientific Biopharmaceutical CDMO Product Portfolio

13.8.3 Thermo Fisher Scientific Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 AGC Biologics

13.9.1 AGC Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 AGC Biologics Biopharmaceutical CDMO Product Portfolio

13.9.3 AGC Biologics Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Rentschler Biopharma

13.10.1 Rentschler Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Rentschler Biopharma Biopharmaceutical CDMO Product Portfolio

13.10.3 Rentschler Biopharma Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 KBI Biopharma

13.11.1 KBI Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 KBI Biopharma Biopharmaceutical CDMO Product Portfolio

13.11.3 KBI Biopharma Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Siegfried

13.12.1 Siegfried Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Siegfried Biopharmaceutical CDMO Product Portfolio

13.12.3 Siegfried Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Aenova Group

13.13.1 Aenova Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Aenova Group Biopharmaceutical CDMO Product Portfolio

13.13.3 Aenova Group Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 GenScript

13.14.1 GenScript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 GenScript Biopharmaceutical CDMO Product Portfolio

13.14.3 GenScript Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 ProBioGen

13.15.1 ProBioGen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 ProBioGen Biopharmaceutical CDMO Product Portfolio

13.15.3 ProBioGen Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Northway Biotech

13.16.1 Northway Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Northway Biotech Biopharmaceutical CDMO Product Portfolio

13.16.3 Northway Biotech Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 3P Biopharmaceuticals

13.17.1 3P Biopharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 3P Biopharmaceuticals Biopharmaceutical CDMO Product Portfolio

13.17.3 3P Biopharmaceuticals Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Biopharmaceutical CDMO Industry Chain Analysis

14.2 Biopharmaceutical CDMO Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Biopharmaceutical CDMO Typical Downstream Customers

14.4 Biopharmaceutical CDMO Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support